Wiwatchai Sittiwong
Bangkok, Thailand
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 15 publications
Corrigendum to "Pre-Treatment and Pre-Brachytherapy MRI First-Order Radiomic Features by a Commercial Software as Survival Predictors in Radiotherapy for Cervical Cancer" [Clin. Transl. Radiat. Oncol. 53 (2025) 100965].
Journal: Clinical and translational radiation oncology
Published: June 22, 2026
Corrigendum to "Long-term outcomes from a multicentre study of HDR monotherapy with a single fraction of 19 Gy for localized prostate cancer" [Radiother. Oncol. 216 (2026) 111385].
Journal: Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology
Published: April 10, 2026
Correction: Re-irradiation in oligorecurrence and oligometastatic cervical cancer in modern radiotherapy era.
Journal: Radiation oncology (London, England)
Published: March 28, 2026
Comment on TWO Versus Five-fraction Magnetic Resonance-Guided Adaptive Radiotherapy with DOminant-TArgeted Boost in Localized Prostate Cancer (DOTA-2): Interim Acute Toxicity Analysis of the Phase II Randomised Trial.
Journal: Clinical oncology (Royal College of Radiologists (Great Britain))
Published: February 20, 2026
Long-term outcomes from a multicentre study of HDR monotherapy with a single fraction of 19 Gy for localized prostate cancer.
Journal: Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology
Published: October 15, 2025
Re-irradiation in oligorecurrence and oligometastatic cervical cancer in modern radiotherapy era.
Journal: Radiation oncology (London, England)
Published: July 29, 2025
Two Versus Five-Fraction Magnetic Resonance-Guided Adaptive Radiotherapy with DOminant-TArgeted Boost in Localized Prostate Cancer (DOTA-2): Interim Acute Toxicity Analysis of the Phase II Randomised Trial.
Journal: Clinical oncology (Royal College of Radiologists (Great Britain))
Published: April 24, 2025
Early Results of Hypofractionated Chemoradiation in Cervical Cancer with 44 Gy/ 20 F vs 45 Gy/ 25 F: A Phase II, Open-Label, Randomised Controlled Trial (HYPOCx-iRex Trial).
Journal: Clinical oncology (Royal College of Radiologists (Great Britain))
Published: September 28, 2024
Clinical outcomes of using 3D-printed applicators for high-dose-rate brachytherapy in gynecological malignancy.
Journal: Journal of contemporary brachytherapy
Published: September 16, 2024
Pre-Treatment and Pre-Brachytherapy MRI first-order Radiomic Features by a Commercial software as survival predictors in radiotherapy for cervical cancer Objectives.
Journal: Clinical and translational radiation oncology
Published: April 28, 2024
Pre-treatment T2-weighted magnetic resonance radiomics for prediction of loco-regional recurrence after image-guided adaptive brachytherapy for locally advanced cervical cancer.
Journal: Journal of contemporary brachytherapy
Published: March 03, 2024
Clinical Outcome Comparison between CT-Guided Versus all MRI-Guided Scenarios in Brachytherapy for Cervical Cancer: A Single-Institute Experience.
Journal: Clinical oncology (Royal College of Radiologists (Great Britain))
Published: February 20, 2024
Last Updated: 09/26/2026